Adam J Rubenis1, Rebecca E Fitzpatrick1, Dan I Lubman2,3, Antonio Verdejo-Garcia1. 1. Monash Institute of Cognitive and Clinical Neurosciences, Monash University, Clayton, VIC, Australia. 2. Turning Point, Eastern Health, Fitzroy, VIC, Australia. 3. Eastern Health Clinical School, Monash University, Fitzroy, VIC, Australia.
Abstract
BACKGROUND AND AIMS: Methamphetamine dependence is associated with heightened impulsivity and diminished quality of life, but the link between impulsivity and changes in quality of life during treatment has not been examined. We aimed to investigate how different elements of impulsivity predict change in quality of life in the 6 weeks after engaging in treatment. DESIGN: Longitudinal, observational cohort study. SETTING: Public and private detoxification and rehabilitation facilities in metropolitan Melbourne, Australia. PARTICIPANTS: One hundred and eight individuals with methamphetamine dependence (81 male) tested within 3 weeks of commencing treatment; 80 (74%) were followed-up at 6 weeks. MEASUREMENTS: The Continuous Performance Test-2 measured impulsive action (cognitive and motor impulsivity); the Delay Discounting Task measured impulsive choice. Quality of life was measured with the World Health Organization Quality of Life Scale-Brief, which includes social, psychological, physical and environment domains. Control variables included age, gender, estimated IQ, depression severity score, methamphetamine dependence severity score, cannabis dependence severity score and treatment modality. FINDINGS: We found that all three forms of impulsivity were significant predictors of change in the social domain: motor impulsivity (β = -0.54, P = 0.013), cognitive impulsivity (β = -0.46, P = 0.029) and impulsive choice (β = -0.26, P = 0.019). Change in the psychological domain was predicted significantly by motor impulsivity (β = -0.45, P = 0.046). Control variables of age and depression were associated significantly with changes in the physical domain. CONCLUSIONS: In Australian methamphetamine-dependent individuals, elevated impulsivity predicts lower improvement of social and psychological quality of life in the first 6-9 weeks of treatment.
BACKGROUND AND AIMS: Methamphetamine dependence is associated with heightened impulsivity and diminished quality of life, but the link between impulsivity and changes in quality of life during treatment has not been examined. We aimed to investigate how different elements of impulsivity predict change in quality of life in the 6 weeks after engaging in treatment. DESIGN: Longitudinal, observational cohort study. SETTING: Public and private detoxification and rehabilitation facilities in metropolitan Melbourne, Australia. PARTICIPANTS: One hundred and eight individuals with methamphetamine dependence (81 male) tested within 3 weeks of commencing treatment; 80 (74%) were followed-up at 6 weeks. MEASUREMENTS: The Continuous Performance Test-2 measured impulsive action (cognitive and motor impulsivity); the Delay Discounting Task measured impulsive choice. Quality of life was measured with the World Health Organization Quality of Life Scale-Brief, which includes social, psychological, physical and environment domains. Control variables included age, gender, estimated IQ, depression severity score, methamphetamine dependence severity score, cannabis dependence severity score and treatment modality. FINDINGS: We found that all three forms of impulsivity were significant predictors of change in the social domain: motor impulsivity (β = -0.54, P = 0.013), cognitive impulsivity (β = -0.46, P = 0.029) and impulsive choice (β = -0.26, P = 0.019). Change in the psychological domain was predicted significantly by motor impulsivity (β = -0.45, P = 0.046). Control variables of age and depression were associated significantly with changes in the physical domain. CONCLUSIONS: In Australian methamphetamine-dependent individuals, elevated impulsivity predicts lower improvement of social and psychological quality of life in the first 6-9 weeks of treatment.
Authors: Alexandra C Anderson; Alex H Robinson; Eden Potter; Bronte Kerley; Daphne Flynn; Dan I Lubman; Antonio Verdejo-García Journal: Front Psychiatry Date: 2022-04-25 Impact factor: 5.435
Authors: Craig R Rush; Justin C Strickland; Erika Pike; Christina R Studts; William W Stoops Journal: Drug Alcohol Depend Date: 2019-12-16 Impact factor: 4.492
Authors: Marichelle C Leclair; Ashley J Lemieux; Laurence Roy; Michael S Martin; Eric A Latimer; Anne G Crocker Journal: Can J Psychiatry Date: 2019-11-25 Impact factor: 4.356
Authors: Antonio Verdejo-Garcia; Valentina Lorenzetti; Victoria Manning; Hugh Piercy; Raimondo Bruno; Rob Hester; David Pennington; Serenella Tolomeo; Shalini Arunogiri; Marsha E Bates; Henrietta Bowden-Jones; Salvatore Campanella; Stacey B Daughters; Christos Kouimtsidis; Dan I Lubman; Dieter J Meyerhoff; Annaketurah Ralph; Tara Rezapour; Hosna Tavakoli; Mehran Zare-Bidoky; Anna Zilverstand; Douglas Steele; Scott J Moeller; Martin Paulus; Alex Baldacchino; Hamed Ekhtiari Journal: Front Psychiatry Date: 2019-12-23 Impact factor: 4.157
Authors: Shalini Arunogiri; Antonio Verdejo-Garcia; Rebecca McKetin; Adam J Rubenis; Rebecca E Fitzpatrick; Dan I Lubman Journal: Front Psychiatry Date: 2019-12-13 Impact factor: 4.157
Authors: David L Pennington; Jill V Reavis; Monique T Cano; Erica Walker; Steven L Batki Journal: Front Behav Neurosci Date: 2022-03-22 Impact factor: 3.558
Authors: Elise E DeVito; Andrea H Weinberger; Raina D Pang; Nicole Petersen; Tessa Fagle; Alicia M Allen Journal: Curr Behav Neurosci Rep Date: 2020-07-15